FDA clears J&J's chemotherapy for certain soft tissue sarcomas

(Reuters) - The U.S. Food and Drug Administration said it approved Johnson & Johnson's chemotherapy to treat specific soft-tissue sarcomas (STS) that have spread to other parts of the body or cannot be removed by surgery.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news